Previous studies have shown that miR-370 can promote liver cancer cell apoptosis by targeting the AKT signaling and inhibits glioma cell proliferation and bladder cancer metastasis by targeting the β-catenin [38, 41, 42]. Here, AKT1 is linked to glioma.